Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| Alan Hall Jobe, MD-PHD | Prediction of Fetal Maturity and Neonatal Morbidity Using Novel Biomarkers from Cell-Free Amniotic Fluid Transcriptome | National Institutes of Health (NIH) | R21HD096256 | 05/01/2020 - 04/30/2021 | $196,187 |
| Jeffrey A Whitsett, MD Anjaparavanda Naren, PHD John Paul Clancy, MD |
Personalized Cystic Fibrosis Therapy and Research Center | National Institutes of Health (NIH) | P30DK117467 | 07/01/2019 - 06/30/2020 | $387,690.33 |
| Anne Karina Perl, PHD | Interstitial resident fibroblasts direct alveolar epithelial differentiation | National Institutes of Health (NIH) | R01HL131661 | 12/01/2019 - 11/30/2020 | $452,054 |
| Anne Karina Perl, PHD | LAM cells reprogram the epithelial-mesenchymal crosstalk in the alveolar niche | The LAM Foundation | LAM0138E01-19 | 01/15/2020 - 01/14/2021 | $66,667 |
| Anne M White, MD | Soap and Water as Simple and Adequate Reprocessing in Low-Resource Settings: A Pilot Study | Laerdal Foundation | 40415 | 07/01/2019 - 06/30/2020 | $25,000 |
| Arun Pradhan, PHD | Development of FOXF1-activating small molecule compound for the treatment of Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) | National Organization for Rare Disorders | NORD ID 17001 | 04/13/2019 - 04/12/2020 | $25,000 |
| Brenda Poindexter, MD-MS | Developmental Impact of NICU Exposures (DINE) | Albert Einstein College of Medicine (National Institutes of Health) | 311397 | 09/01/2019 - 08/31/2020 | $75,965 |
| Brenda Poindexter, MD-MS | 1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRID Outcomes Study): Clinical Coordinating Center | Children's Hospital of Philadelphia (National Institutes of Health) | 3200930818 | 09/01/2017 - 08/31/2019 | $4,000 |
| Brenda Poindexter, MD-MS | NICHD Cooperative Multicenter Neonatal Research Network | National Institutes of Health (NIH) | UG1HD027853 | 04/01/2020 - 03/31/2021 | $268,102 |
| Brenda Poindexter, MD-MS | HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium | RTI International (National Institutes of Health) | OBOE | 09/01/2019 - 08/31/2020 | $50,000 |
| Brenda Poindexter, MD-MS | High-dose Erythropoietin for Asphyxia and Encephalopathy | The Regents of the Univ of California (National Institutes of Health) | U01NS092764 | 07/01/2019 - 06/30/2020 | $26,676 |
| Bruce C Trapnell, MD | Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis | National Institutes of Health (NIH) | R01HL118342 | 07/01/2019 - 06/30/2020 | $459,701 |
| Bruce C Trapnell, MD | Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP | National Institutes of Health (NIH) | R01HL085453 | 05/01/2020 - 04/30/2021 | $397,500 |
| Bruce C Trapnell, MD | Multicenter Interventional Lymphangioleiomyomatosis Earl | University of Cincinnati (National Institutes of Health) | 010575-008 | 07/01/2019 - 06/30/2020 | $57,173 |
| Daniel Todd Swarr, MD | The role of the long non-coding RNA Falcor in early endoderm and lung development | National Institutes of Health (NIH) | K08HL130666 | 12/01/2019 - 11/30/2020 | $162,540 |
| Debora Ines Sinner, PHD | Molecular mechanisms underlying trachea formation and the pathology of tracheomalacia and complete tracheal rings | National Institutes of Health (NIH) | R01HL44774-01A1 | 04/01/2020 - 03/31/2021 | $446,835 |
| Hitesh Deshmukh, MD-PHD | Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria | National Institutes of Health (NIH) | 0002360 | 09/01/2019 - 08/31/2020 | $417,649 |
| Hitesh Deshmukh, MD-PHD | Role of Microbiome in Neonatal Lung Maturation and Immune Susceptibility | The Regents of the Univ of California (National Institutes of Health) | A18-0659-S001 | 03/01/2019 - 02/29/2020 | $78,309 |
| James M Greenberg, MD | HRSA Cradle Cincinnati | Health Resources & Services Admin | H49MC27823 | 04/01/2020 - 03/31/2021 | $1,122,899 |
| James M Greenberg, MD | ODH - Infant Vitality Community Intensive Pilot Project FY 20 | Ohio Department of Health | 03130011IV0220 | 07/01/2019 - 06/30/2020 | $500,000 |
| James M Greenberg, MD | Mom's Quit for Two | Ohio Department of Health | 03130011MQ0120 | 07/01/2019 - 06/30/2020 | $157,698 |
| Jason J Gokey, PHD | Role of Epithelial YAP in Alveolar Progenitor Cell Differentiation & Maintenance | University of Maryland (Baltimore) (National Institutes of Health) | 1701192 | 12/01/2019 - 06/30/2020 | $10,000 |
| Jeffrey A Whitsett, MD Xinhua Lin, PHD |
Role of EMC3/TMEM111 in Alveolar Epithelial Cell Function | National Institutes of Health (NIH) | R01HL136722 | 04/01/2020 - 03/31/2021 | $269,708 |
| Jeffrey A Whitsett, MD Yan Xu, PHD S Steven Potter, PHD |
LungMap Phase II - Building a multidimensional map of developing human lung | National Institutes of Health (NIH) | U01HL148856 | 08/23/2019 - 07/31/2020 | $598,206.67 |
| Kristen Suhrie, MD | Precision Medicine in the Diagnosis of Genetic Disorders in Neonates | Tufts Medical Center (National Institutes of Health) | 5016131-SERV | 08/15/2018 - 07/31/2019 | $9,540 |
| Kristen Suhrie, MD | Precision Medicine in the Diagnosis of Genetic Disorders in Neonates | Tufts Medical Center (National Institutes of Health) | 5016131-SERV | 08/01/2019 - 07/31/2020 | $71,292 |
| Kurt Schibler, MD | Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms - CCC | University of Utah (National Institutes of Health) | 10053175-02 | 01/02/2019 - 05/31/2020 | $30,628 |
| Lili He, PHD | Early Prediction of Cognitive Deficits in Very Preterm Infants Using Machine Learning and Brain Connectome | National Institutes of Health (NIH) | R21HD094085 | 08/01/2019 - 07/31/2020 | $238,500 |
| Nehal A Parikh DO | A New Model to Identify Preterm Neonates at High-Risk for Cognitive Deficits | National Institutes of Health (NIH) | R01NS094200 | 02/01/2020 - 01/31/2021 | $344,116 |
| Nehal A Parikh DO | Early Prediction of Cerebral Palsy in Premature Infants using Advanced MRI Biomarkers | National Institutes of Health (NIH) | R01NS096037 | 06/01/2020 - 05/31/2021 | $331,820 |
| Paul Kingma, MD-PHD Aaron Zorn PHD and James Well, PHD |
Developmental Mechanisms of Trachea-Esophageal Birth Defects | National Institutes of Health (NIH) | P01HD093363 | 06/01/2020 - 05/31/2021 | $881,765.33 |
| Scott Lewis Wexelblatt, MD | Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network "MOMS Developing Research protocol/Providing expertise for Implementing CTN Trial | University of Cincinnati (National Institutes of Health) | 009942-031 | 06/01/2019 - 05/31/2020 | $19,067 |
| Sing Sing Way, MD-PHD | March of Dimes Prematurity Research Center Ohio Collaborative Renewal | March of Dimes National | #22-FY19-347 | 07/01/2019 - 09/30/2020 | $1,000,000 |
| Stephanie L Merhar, MD | 4/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study | Department of Health and Human Services | R34DA050268 | 09/30/2019 - 03/31/2021 | $536,625 |
| Stephanie L Merhar, MD | Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network "MOMS Developing Research protocol/Providing expertise for Implementing CTN Trial | University of Cincinnati (National Institutes of Health) | 009942-24 | 01/01/2020 - 05/31/2020 | $8,090 |
| Takuji Suzuki, PHD | Genome edited iPS cell-derived macrophages as a novel lung cell therapy | National Institutes of Health (NIH) | R01HL136721 | 02/01/2020 - 01/31/2021 | $390,000 |
| Tatiana Viktorovna Kalin, MD-PHD | Targeting Foxm1 in pulmonary fibrosis | National Institutes of Health (NIH) | R01HL132849 | 07/01/2019 - 06/30/2021 | $390,000 |
| Timothy D LeCras, PHD | Characterizing the formation and function of bone lymphatics | The University of Texas Southwestern (National Institutes of Health) | R01HL144793 | 01/01/2020 - 12/31/2020 | $35,603 |
| Timothy D LeCras, PHD | Pathogenesis of Lymphatic Anomalies | Tiffany and Danny Ferry | LeCras | 05/01/2020 - 04/30/2021 | $163,525 |
| Vladimir V Kalinichenko, MD-PHD | Transcriptional Regulation of Endothelial Cells after Acute Lung Injury | National Institutes of Health (NIH) | R01HL141174 | 04/01/2020 - 03/31/2021 | $524,323 |
| Vladimir V Kalinichenko, MD-PHD | Molecular Mechanisms Regulated by FOXM1 in Chronic Lung Remodeling | National Institutes of Health (NIH) | 573R01HL149631 | 06/01/2020 - 05/31/2021 | $573,748 |
| William John Zacharias, MD-PHD | Mechanistic evaluation of a novel Wnt-responsive adult alveolar epithelial progenitor population during regeneration after diffuse alveolar damage | National Institutes of Health (NIH) | K08HL140178 | 07/01/2019 - 06/30/2020 | $163,080 |
| Yan Xu, PHD | Decoding the Cellular Niches Critical for Lung Maturation and Pathogenesis | University of California San Diego (National Institutes of Health) | 125063615 | 07/01/2019 - 06/30/2020 | $42,216 |
| Yutaka Maeda, PHD | Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung | National Institutes of Health (NIH) | R01CA240317 | 04/01/2020 - 03/31/2021 | $661,391 |
| Current Year Direct | $12,670,889.33 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Bruce C Trapnell, MD | Vertex Pharmaceutical Incorporated | $81,792.00 |
| Jeffrey A Whitsett, MD | Northwestern University Medical School (Chan Zuckerberg Initiative) | $28,936.00 |
| Vivek Narendran, MD | MedImmune, Inc. | $419,526.00 |
| Total Annual Industry Award Dollars | $530,254.00 | |
